Stocks and Investing Stocks and Investing
Mon, July 18, 2022

David Windley Maintained (UNH) at Hold with Increased Target to $513 on, Jul 18th, 2022


Published on 2024-10-27 21:59:04 - WOPRAI, David Windley
  Print publication without navigation


David Windley of Jefferies, Maintained "UnitedHealth Group Incorporated" (UNH) at Hold with Increased Target from $487 to $513 on, Jul 18th, 2022.

David has made no other calls on UNH in the last 4 months.



There are 12 other peers that have a rating on UNH. Out of the 12 peers that are also analyzing UNH, 3 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Lance Wilkes of "Bernstein" Downgraded from Buy to Hold and Held Target at $561 on, Friday, May 27th, 2022
  • Matt Borsch of "BMO Capital" Maintained at Hold with Increased Target to $600 on, Tuesday, April 19th, 2022
  • Kevin Caliendo of "UBS" Maintained at Hold with Increased Target to $545 on, Wednesday, April 13th, 2022


These are the ratings of the 9 analyists that currently disagree with David


  • Joseph France of "Loop Capital" Initiated at Strong Buy and Held Target at $575 on, Friday, June 17th, 2022
  • Stephen Baxter of "Wells Fargo" Maintained at Buy with Decreased Target to $612 on, Wednesday, May 25th, 2022
  • Kevin Fischbeck of "B of A Securities" Maintained at Strong Buy and Held Target at $632 on, Wednesday, May 11th, 2022
  • John Ransom of "Raymond James" Maintained at Strong Buy with Increased Target to $620 on, Tuesday, April 19th, 2022
  • George Hill of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $549 on, Monday, April 18th, 2022
  • Ben Hendrix of "RBC Capital" Maintained at Buy with Increased Target to $588 on, Monday, April 18th, 2022
  • Lisa Gill of "JP Morgan" Maintained at Buy with Increased Target to $595 on, Monday, April 18th, 2022
  • David Macdonald of "Truist Securities" Maintained at Strong Buy with Increased Target to $610 on, Thursday, April 7th, 2022
  • Steve Valiquette of "Barclays" Maintained at Buy with Increased Target to $565 on, Wednesday, March 30th, 2022
Contributing Sources